gemcitabine, oxaliplatin

DRUG3 trials

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris, National Health Research Institutes, Taiwan, Yonsei University

Conditions

Adenocarcinoma of GallbladderCarcinoma, Transitional CellCholangiocarcinomaHepatocellular Carcinoma, Unresectable, Advanced

Phase 2

Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

TerminatedNCT00127595

Gustave Roussy, Cancer Campus, Grand ParisCarcinoma, Transitional Cell

Start: 2002-01-31End: 2005-04-30Target: 28Updated: 2005-08-24

A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC

CompletedNCT01267344

National Health Research Institutes, TaiwanAdenocarcinoma of Gallbladder, Cholangiocarcinoma

Start: 2010-12-31End: 2015-05-31Updated: 2016-05-04

Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

CompletedNCT05517239

Yonsei UniversityHepatocellular Carcinoma, Unresectable, Advanced

Start: 2015-05-01End: 2020-09-30Updated: 2022-08-26

Related Papers

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.

2015-01-28118 citations